Evidence map›Paper›PMID 31871086›Full record

ArticleAntimicrobial agents and chemotherapy2020

Omadacycline Efficacy against Enterococcus faecalis Isolated in China:

Zhiwei Lin, Zhangya Pu, Guangjian Xu, Bing Bai, Zhong Chen, Xiang Sun, Jinxin Zheng, Peiyu Li, Di Qu, Qiwen Deng and 1 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Non-Clinical microbiology reviews · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Omadacycline Efficacy againstComputational intelligence and neuroscience · 2022
    Article
  12. Acquisition of Daptomycin Resistance byFrontiers in microbiology · 2022
    Article
  13. Annals of laboratory medicine · 2021
    Article
  14. Article
  15. Article
  16. Mechanism of Eravacycline Resistance in ClinicalFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhiwei Lin *Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, China.
Zhangya Pu *Department of Infectious Diseases, Key Laboratory of Viral Hepatitis of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Guangjian Xu *Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, China.
Bing BaiDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, China.
Zhong ChenDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, China.
Xiang SunDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, China.
Jinxin ZhengDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, China.
Peiyu LiDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, China.
Di QuKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Science and Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, Shanghai, China.
Qiwen DengDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, China qiwendeng@hotmail.com yuzhijiansmu@163.com.
Zhijian YuDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, China qiwendeng@hotmail.com yuzhijiansmu@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the

Indexed as

Anti-Bacterial AgentsChinaEnterococcus faecalisMicrobial Sensitivity TestsMultilocus Sequence TypingMutationRibosome Subunits, Small, BacterialSequence Analysis, RNATetracyclinesAnti-Bacterial AgentsomadacyclineTetracyclinesEnterococcus faecalisheteroresistancemultilocus sequence typingomadacyclinetetracycline-specific resistance genes

Identifiers

PMID31871086
PMCPMC7038293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.